DK 021:2015:33650000-1 General anti-infectives for systemic use, vaccines, antineoplastic agents and immunomodulators (Pazopanib film-coated tablets, 400 mg INN:Pazopanib, Fulvestrant, solution for infusion, 50 mg/ml (250 mg/5 ml), 5 ml each, syringe INN:Fulvestrant:, Abiraterone, tablets 250 mg INN:Abiraterone)
Original title (Ukrainian): ДК 021:2015:33650000-1 Загальні протиінфекційні засоби для системного застосування, вакцини, антинеопластичні засоби та імуномодулятори (Пазопаніб таблетки, вкриті плівковою оболонкою, 400 мг МНН:Pazopanib; Фулвестрант, розчин для інфузій, 50 мг/мл (250 мг/5 мл), по 5 мл, шприц МНН:Fulvestrant:; Абіратерон, таблетки по 250 мг МНН:Abiraterone)
International buyer · Ukraine government procurement
Closed April 28, 2026. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.
Країною-походження товару не може бути Російська Федерація/ Республіка Білорусь/ Ісламська Республіка Іран Method: priceQuotation Items: Абіратерон, таблетки по 250 мг | Пазопаніб таблетки, вкриті плівковою оболонкою, 400 мг | Фулвестрант, розчин для інфузій, 50 мг/мл (250 мг/5 мл), по 5 мл, шприц Classification: Загальні протиінфекційні засоби для системного застосування, вакцини, антинеопластичні засоби та імуномодулятори | Abiraterone | Антинеопластичні засоби та імуномодулятори
Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start Free| Issuing agency | International buyer |
|---|
| Country | Ukraine |
|---|
| Category | Pharmaceuticals |
|---|
| Estimated value | $120,320 |
|---|
| Published | April 28, 2026 |
|---|
| Procurement stage | Active solicitation |
|---|
| Closed | April 28, 2026 |
|---|
| Status | Closed — no longer accepting responses |
|---|
| Original language | Ukrainian — members read it in their own language |
|---|
| Official source | View original notice |
|---|
| Last verified | October 09, 2026 |
|---|
Source: Prozorro (Ukraine) — open contracting data. Not affiliated with the Government of Ukraine.
See every Ukraine Pharmaceuticals opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Used by capture teams who win by looking where the big players aren’t.
Get a free Ukraine Pharmaceuticals intelligence report in your inbox
A personalized report on Ukraine Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.